Jennifer DeVoe, M.D., D.Phil., associate professor of family medicine, OHSU School of Medicine, has been elected to the Institute of Medicine (IMO), one of the highest honors in the fields of health and medicine. Dr. DeVoe, a family physician and health services researcher and chief research officer at the Oregon Community Health Information Network (OCHIN), was elected in recognition of her outstanding professional achievement and commitment to services in health and medicine. “I am humbled … Read More
Posts Tagged ‘OHSU in the news’
A new study published by researchers at Oregon Health & Science University shows that the Physician Orders for Life-Sustaining Treatment program–commonly known as POLST–is effective in honoring end-of-life wishes for frail or seriously ill patients. By reviewing death records from 58,000 Oregonians, the researchers found that only 6.4% of patients who asked for comfort measures only on their POLST form died in a hospital, whereas 44.2% of patients who asked for full medical treatment died in … Read More
Oregon Health & Science University has just announced a new Center for Embryonic Cell and Gene Therapy to be led by Shoukhrat Mitalipov, Ph.D., senior scientist at OHSU’s Oregon National Primate Research Center and world leader in embryonic stem cell and gene therapy research. In May 2013, Dr. Mitalipov and his colleagues received significant attention after publishing a paper in Cell describing a new process for creating human embryonic stem cells from skin cells. The discovery was named a top … Read More
As we wrap up 2013, several publications have issued Top 10 lists for 2013. Shoukhrat Mitalipov, Ph.D., a senior scientist at the Oregon National Primate Research Center, has been recognized by four national publications —Time, Nature, Science, and Discover—for being the first person to transform human skin cells into embryonic stem cells using a technique called somatic cell nuclear transfer. The discovery holds promise for treating conditions such as Parkinson’s disease, multiple sclerosis, cardiac disease and spinal cord injuries.
This afternoon, OHSU announced a $125 million gift from Nike co-founder and Chairman Phil Knight and his wife Penny that will establish a new cardiovascular institute at OHSU. This is the Knights’ second landmark gift to OHSU–in 2008 they gave $100 million to fund the OHSU Knight Cancer Institute–and the largest in OHSU history. Under the leadership of Albert Starr, M.D., co-inventor of the world’s first successful heart valve, and Sanjiv Kaul, M.D., an innovator … Read More
In 2011, OHSU’s Mother-Baby Unit stopped routine distribution of pacifiers to breastfeeding newborns in accordance with recommendations by the Joint Commission and the American Academy of Pediatrics. Their goal was to increase the number of infants in the unit who were breastfed only and received no supplemental formula. What happened, though, was quite the opposite. When the no-pacifier policy was implemented, the percent of exclusively breastfed infants dropped from 79 to 68 percent. During the … Read More
According to a study by lead author Erick Turner, M.D., assistant professor of psychiatry and pharmacology, physicians who prescribe antipsychotic medications may be doing so based on incomplete information. Dr. Turner and his colleagues found that while overall, antipsychotic medications appear to be more effective than placebos in clinical trials, sometimes the results of these studies are not published, or articles are written in such a way that overstates a drug’s effectiveness. For example, there … Read More
Don’t miss the op-ed in today’s print and online editions of The Oregonian, written by Mark Richardson, M.D., Dean of the School of Medicine, and Dan Dorsa, Ph.D., Vice President for Research. In the article, Drs. Richardson and Dorsa argue that federal funding for biomedical research is vital to both Oregon’s health and economy. Do you agree? Share the article with your friends and family. View the article on OregonLive.com.